Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
325.72
264.86
298.01
290.08
231.35
195.88
230.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
325.72
264.86
298.01
290.08
231.35
195.88
230.04
Raw Material Cost
64.12
66.17
59.82
67.19
57.37
46.09
70.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.39
4.53
4.54
4.52
4.52
4.51
5.22
Selling and Distribution Expenses
41.61
42.36
42.25
41.24
35.71
35.13
37.61
Other Expenses
1.31
1.03
1.59
1.39
1.65
1.46
1.61
Total Expenditure (Excl Depreciation)
123.28
123.33
122.51
126.89
114.12
100.34
129.00
Operating Profit (PBDIT) excl Other Income
202.39999999999998
141.5
175.5
163.2
117.2
95.5
101
Other Income
6.89
6.82
7.25
6.47
5.03
4.99
5.36
Operating Profit (PBDIT)
229.79
168.80
203.17
190.03
142.63
120.74
127.09
Interest
4.39
4.53
4.54
4.52
4.52
4.51
5.22
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
261.60
198.70
238.19
222.90
173.98
149.79
159.98
Depreciation
20.46
20.45
20.41
20.36
20.36
20.21
20.69
Profit Before Tax
204.94
143.83
178.21
165.15
117.74
96.03
101.17
Tax
39.78
25.73
41.20
28.14
24.50
19.20
15.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
165.16
118.09
137.01
137.01
93.25
76.82
85.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
165.16
118.09
137.01
137.01
93.25
76.82
85.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
165.16
118.09
137.01
137.01
93.25
76.82
85.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
332.75
482.27
363.82
452.70
289.42
177.81
83.81
Earnings per share (EPS)
1.33
0.93
1.06
1.05
0.72
0.6
0.65
Diluted Earnings per share
1.33
0.93
1.06
1.05
0.72
0.6
0.65
Operating Profit Margin (Excl OI)
62.15%
53.44%
58.89%
56.26%
50.67%
48.78%
43.92%
Gross Profit Margin
69.2%
62.02%
66.65%
63.95%
59.69%
59.34%
52.98%
PAT Margin
50.71%
44.59%
45.98%
47.23%
40.3%
39.22%
37.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 22.95% vs -11.11% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 39.88% vs -13.80% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 37.59% vs -17.30% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -2.22% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Halozyme Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
325.72
1,241.00
-915.28
-73.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
325.72
1,241.00
-915.28
-73.75%
Raw Material Cost
64.12
664.00
-599.88
-90.34%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.39
70.00
-65.61
-93.73%
Selling and Distribution Expenses
41.61
400.00
-358.39
-89.60%
Other Expenses
1.31
2.20
-0.89
-40.45%
Total Expenditure (Excl Depreciation)
123.28
1,156.00
-1,032.72
-89.34%
Operating Profit (PBDIT) excl Other Income
202.44
85.00
117.44
138.16%
Other Income
6.89
2.00
4.89
244.50%
Operating Profit (PBDIT)
229.79
256.00
-26.21
-10.24%
Interest
4.39
70.00
-65.61
-93.73%
Exceptional Items
0.00
8.00
-8.00
-100.00%
Gross Profit (PBDT)
261.60
577.00
-315.40
-54.66%
Depreciation
20.46
169.00
-148.54
-87.89%
Profit Before Tax
204.94
25.00
179.94
719.76%
Tax
39.78
14.00
25.78
184.14%
Provisions and contingencies
0
0
0.00
Profit After Tax
165.16
11.00
154.16
1,401.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
165.16
11.00
154.16
1,401.45%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
165.16
11.00
154.16
1,401.45%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
332.75
6,775.00
-6,442.25
-95.09%
Earnings per share (EPS)
1.33
0.02
1.31
6,550.00%
Diluted Earnings per share
1.33
0.02
1.31
6,550.00%
Operating Profit Margin (Excl OI)
62.15%
6.85%
0.00
55.30%
Gross Profit Margin
69.20%
15.63%
0.00
53.57%
PAT Margin
50.71%
0.89%
0.00
49.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 32.57 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 22.95% vs -11.11% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 40.75% vs 4.71% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.52 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 39.88% vs -13.80% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 77.25% vs 24.60% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.29 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 37.59% vs -17.30% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 61.99% vs 19.55% in Jun 2024
Quarterly - Interest
Interest 0.44 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -2.22% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.22% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 62.15%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
